Position in ARDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$624,158
-$46,292 QoQ
Shares Held
104,200
-9.4% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Mar 31, 2026CallValue
$898,500
CallShares
150,000
PutValue
$1,198,000
PutShares
200,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Caption Management, LLC holds $196,103,961 across 70 Biotechnology names. ARDX ranks #41 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
378,480 | $25,615,526 | |
| 2 | IMCR |
Immunocore Holdings plc
|
661,786 | $19,952,847 | |
| 3 | CYTK |
Cytokinetics Inc
|
245,000 | $16,147,950 | |
| 4 | ELVN |
Enliven Therapeutics, Inc.
|
370,000 | $14,504,000 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
420,143 | $14,066,387 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
274,116 | $10,887,887 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
260,000 | $10,480,600 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
272,292 | $7,626,898 |
All Filings in ARDX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $624,158 | 104,200 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,198,000 | 200,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $898,500 | 150,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $240,196 | 41,200 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $670,450 | 115,000 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $511,560 | 130,500 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $202,800 | 40,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $175,422 | 34,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $275,600 | 40,000 | Call | Sole | 2024-11-14 | |
| 2023-12-31 | $124,000 | 20,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $325,500 | 52,500 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $121,520 | 19,600 | Call | Sole | 2024-02-14 | |
| 2022-12-31 | $110,580 | 38,800 | Call | Sole | 2023-02-14 | |
| 2020-12-31 | $122,930 | 19,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||